Pfizer's with an answer for kids covid 19 vaccines?
The findings from Pfizer are scheduled to be released in September. FDA will be ready to accept Pfizer by mid-fall or first winter, according to Gottlieb. He went on to say that the choice would most likely be dependent on the country's COVID-19 status at the moment, as well as the necessity of immunization children.
Pfizer is currently undertaking studies for kids aged 1 to 2 years old, with findings due in November. According to the previous FDA director, about 300 children are hospitalised to hospitals having COVID-19 every day. Since schools resumed, he said, the prevalence of the virus among youngsters has risen dramatically. He recommended that schools begin evaluating kids twice a week and employ geographic separation to reduce intermingling between student groups.